1-12 of 12
Authors: W. Wolfgang Fleischhacker
Journal Article
Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study Open Access
International Journal of Neuropsychopharmacology, Volume 20, Issue 1, 1 January 2017, Pages 11–21, https://doi.org/10.1093/ijnp/pyw076
Published: 26 August 2016
Journal Article
Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales Open Access
International Journal of Neuropsychopharmacology, Volume 18, Issue 12, November 2015, pyv064, https://doi.org/10.1093/ijnp/pyv064
Published: 26 June 2015
Journal Article
Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature Open Access
International Journal of Neuropsychopharmacology, Volume 18, Issue 10, September 2015, pyv055, https://doi.org/10.1093/ijnp/pyv055
Published: 19 May 2015
Journal Article
Measuring Adherence to Medication in Schizophrenia: The Relationship between Attitudes toward Drug Therapy and Plasma Levels of New-Generation Antipsychotics Open Access
International Journal of Neuropsychopharmacology, Volume 18, Issue 5, March 2015, pyu091, https://doi.org/10.1093/ijnp/pyu091
Published: 29 January 2015
Journal Article
Critical review of antipsychotic polypharmacy in the treatment of schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 17, Issue 7, July 2014, Pages 1083–1093, https://doi.org/10.1017/S1461145712000399
Published: 01 July 2014
Journal Article
Polypharmacy: the good, the bad and the ugly Free
International Journal of Neuropsychopharmacology, Volume 17, Issue 7, July 2014, Page 981, https://doi.org/10.1017/S1461145713000965
Published: 01 July 2014
Journal Article
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial Free
International Journal of Neuropsychopharmacology, Volume 16, Issue 5, June 2013, Pages 987–995, https://doi.org/10.1017/S1461145712001241
Published: 01 June 2013
Journal Article
Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? Free
International Journal of Neuropsychopharmacology, Volume 15, Issue 7, August 2012, Pages 1003–1014, https://doi.org/10.1017/S1461145711001738
Published: 01 August 2012
Journal Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 15, Issue 1, February 2012, Pages 107–118, https://doi.org/10.1017/S1461145711001076
Published: 01 February 2012
Journal Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia – Corrigendum Free
International Journal of Neuropsychopharmacology, Volume 15, Issue 1, February 2012, Page 119, https://doi.org/10.1017/S146114571100160X
Published: 01 February 2012
Journal Article
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial Free
International Journal of Neuropsychopharmacology, Volume 13, Issue 8, September 2010, Pages 1115–1125, https://doi.org/10.1017/S1461145710000490
Published: 01 September 2010
Journal Article
The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 6, Issue 3, September 2003, Pages 201–206, https://doi.org/10.1017/S1461145703003456
Published: 01 September 2003
